Literature DB >> 7877690

ATP-dependent inositide phosphorylation required for Ca(2+)-activated secretion.

J C Hay1, P L Fisette, G H Jenkins, K Fukami, T Takenawa, R A Anderson, T F Martin.   

Abstract

Regulated fusion of secretory granules with the plasma membrane in secretory cells requires ATP, Ca2+ and cytosolic as well as membrane proteins. ATP-dependent steps in Ca(2+)-activated secretion from PC12 cells require three cytosolic PEP proteins (priming in exocytosis proteins, PEP1-3), the identity of which will provide insights into the required ATP-using reactions. PEP3 was recently identified as phosphatidylinositol transfer protein (PtdInsTP), and here we report that PEP1 consists of the type I phosphatidylinositol-4-phosphate 5-kinase (PtdInsP5K). The roles of PEP3/PtdInsTP and PEP1/PtdInsP5K in sequential phosphoinositide recruitment and phosphorylation explains their synergistic activity in ATP-dependent priming. Moreover, inhibition of Ca(2+)-activated secretion by PtdIns(4,5)P2-specific antibodies and phospholipase C implies that 5-phosphorylated inositides play a novel, necessary role in the regulated secretory pathway. The results indicate that lipid kinase-mediated phosphorylation is an important basis for ATP use in the exocytotic pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7877690     DOI: 10.1038/374173a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  154 in total

1.  Early requirement for alpha-SNAP and NSF in the secretory cascade in chromaffin cells.

Authors:  T Xu; U Ashery; R D Burgoyne; E Neher
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells.

Authors:  N Vitale; A S Caumont; S Chasserot-Golaz; G Du; S Wu; V A Sciorra; A J Morris; M A Frohman; M F Bader
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  Solution single-vesicle assay reveals PIP2-mediated sequential actions of synaptotagmin-1 on SNAREs.

Authors:  Jae-Yeol Kim; Bong-Kyu Choi; Mal-Gi Choi; Sun-Ae Kim; Ying Lai; Yeon-Kyun Shin; Nam Ki Lee
Journal:  EMBO J       Date:  2012-03-09       Impact factor: 11.598

4.  Activation of exocytosis by cross-linking of the IgE receptor is dependent on ADP-ribosylation factor 1-regulated phospholipase D in RBL-2H3 mast cells: evidence that the mechanism of activation is via regulation of phosphatidylinositol 4,5-bisphosphate synthesis.

Authors:  G Way; N O'luanaigh; S Cockcroft
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

5.  A novel neuronal-specific splice variant of Type I phosphatidylinositol 4-phosphate 5-kinase isoform gamma.

Authors:  Maria-Luisa Giudici; Piers C Emson; Robin F Irvine
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

6.  Purification and identification of secernin, a novel cytosolic protein that regulates exocytosis in mast cells.

Authors:  Gemma Way; Nicholas Morrice; Carl Smythe; Antony J O'Sullivan
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

Review 7.  Phosphatidylinositol phosphate kinases put PI4,5P(2) in its place.

Authors:  R L Doughman; A J Firestone; R A Anderson
Journal:  J Membr Biol       Date:  2003-07-15       Impact factor: 1.843

Review 8.  Formation, stabilisation and fusion of the readily releasable pool of secretory vesicles.

Authors:  Jakob Balslev Sørensen
Journal:  Pflugers Arch       Date:  2004-03-02       Impact factor: 3.657

Review 9.  Role of phosphoinositides at the neuronal synapse.

Authors:  Samuel G Frere; Belle Chang-Ileto; Gilbert Di Paolo
Journal:  Subcell Biochem       Date:  2012

10.  The yeast and mammalian isoforms of phosphatidylinositol transfer protein can all restore phospholipase C-mediated inositol lipid signaling in cytosol-depleted RBL-2H3 and HL-60 cells.

Authors:  E Cunningham; S K Tan; P Swigart; J Hsuan; V Bankaitis; S Cockcroft
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.